Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea

Clinical trial NCT01568060 · COMPLETED

Trial details

NCT number: NCT01568060
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Acellular Pertussis Diphtheria Tetanus Poliomyelitis Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2012-05-21
Primary completion: 2015-12-15
Enrollment: 645

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.